Recently, we showed that it is possible to reduce VLCFA in fibroblasts from X-ALD patients by inhibiting the synthesis of VLCFA by the enzyme ELOVL1 [3]. This evidence concerns the gene ELOVL1 and adrenoleukodystrophy.